Policy Watch: 20 Regulatory Updates — June 22, 2026
This update covers DEA synthetic opioids schedule I placement actions affecting clinical and regulatory landscapes in 2026. These changes influence substance classification and patient care considerations. Stay informed on the latest controlled…
Policy Watch: DEA Schedule I Placement of Synthetic Cannabinoids — June 08, 2026
This Policy Watch covers DEA synthetic cannabinoids schedule I placement updates for June 08, 2026. These regulatory actions affect clinical and research practices involving controlled substances. Clinicians should stay informed about these changes to…
Policy Watch: Key Synthetic Cannabinoids Schedule I Updates — June 02, 2026
This policy watch highlights synthetic cannabinoids Schedule I updates 2026 with significant clinical and regulatory implications. The DEA's recent actions classify several synthetic cannabinoids as Schedule I substances, affecting clinicians and…
Idaho Medical Cannabis Advocates Report 100,000 Signatures Collected
Idaho medical cannabis ballot initiative advocates have collected 100,000 signatures, marking a significant step toward reform. This initiative aims to improve cannabis access for qualifying patients in Idaho. If successful, it could create a regulated…
Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News
Louisiana is advancing an adult-use cannabis pilot program that aims to provide regulated cannabis products with clearer labeling and safer dosing. This pilot program represents a cautious step toward legalization in a state with strict marijuana laws.…
Extended Moratorium on Oklahoma Medical Marijuana Business Licenses Approved by House
Oklahoma medical cannabis licensing challenges are reshaping the state's medical marijuana market. The extended moratorium on new business licenses and cultivation limits impact dispensary availability and product selection. These regulatory changes…